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A spermine-like polymer was synthesized via reversible addition–fragmentation chain transfer
polymerization as a potential endosomal escaping agent. A new methacrylate monomer, 2-((tert-
butoxycarbonyl)(2-((tert-butoxycarbonyl)amino)ethyl)amino)ethylmethacrylate (BocAEAEMA), was
prepared and then polymerized via RAFT polymerization at constant monomer or initiator concentration
at varying [M]/[R]/[I] ratios. In all polymerizations, ln[M]0/[M] increased linearly with time. The linear
increase in Mn with monomer conversion was also observed. P(BocAEAEMA)s with controlled molecular
weights and narrow molecular weight distributions were obtained. The in vitro cytotoxicity and proton
sponge capacity of deprotected polymers P(AEAEMA) were investigated in comparison with a widely
used endosomal-disruptive polymer, PEI. P(AEAEMA)s were found to possess proton sponge capacity
comparable with PEI. More importantly, P(AEAEMA)s were not toxic on NIH 3T3 cells at concentrations
where PEI (25 kDa) was highly toxic (0.4 mM and above). P(AEAEMA) was able to fully condense a DNA
fragment at nitrogen/phosphate (N/P) ratios of 10 and above, as evidenced by gel electrophoresis.
P(BocAEAEMA) was then chain-extended with a model sugar monomer, mannose-acrylate (ManAc), to
yield P(AEAEMA)-b-P(ManAc) block copolymers, to potentially provide cell-recognition ability to the
polyplex particles. Although the presence of the P(ManAc) block partially inhibited the interaction of
P(AEAEMA) with DNA, P(AEAEMA)13-b-P(ManAc)7 was able to form polyplexes with DNA at N/P ratios
ranging between 20/1 and 2/1. Dynamic light scattering measurements showed that while P(AEAEMA)
(Mn ¼ 5.5 kDa) and DNA formed polyplex particles having a hydrodynamic diameter (Dh) of 125  51 nm,
P(AEAEMA)13-b-P(ManAc)7 and DNA formed particles with a smaller Dh of 38  10 nm.Introduction
Challenges in intracellular delivery of macromolecular bio-
therapeutics (25 kDa) limit the applications of several treatment
strategies such as gene therapies.1–4 Macromolecular thera-
peutics such as DNA and siRNA are usually taken up by cells
through the endocytosis mechanism in which the therapeuticsInstitute of Technology, Gulbahce, Urla,
iyte.edu.tr
arwick, CV4 7AL, Coventry, UK. E-mail:
echnology, Gulbahce, Urla, Izmir, 35430,
e, Queen Mary University of London, Mile
uate Programme, Izmir Institute of
urkey
(ESI) available: ManAC synthesis
s and polymers, calculations of yields,
s and GPC chromatograms. See DOI:
hemistry 2014are entrapped inside acidic membrane vesicles called endo-
somes and then transferred to lysosomes where they get
degraded. There are certain agents displaying the ability to
transport macromolecular therapeutics from endosomes. These
include certain cationic molecules and poly(cations) such as
spermine/spermidine and poly(ethyleneimine) (PEI). Spermine
and spermidine are natural amines that have been used as
endosomal escaping agents in intracellular drug delivery.5–12
Systems containing these natural amines have shown high
biocompatibility, nucleic acid binding activity and transfection
activity. PEI is a synthetic poly(amine) that has also been widely
used in intracellular delivery of genes and nucleic acids.13–16
While PEI displays high transfection ability, high dose-depen-
dent toxicity constitutes its major drawback.16,17 Importantly,
both spermine, spermidine and PEI structures contain primary
and secondary amine groups which cause the proton-sponge
effect in the acidic environment of endosomes, leading to
endosomal rupturing.8,18,19
The reversible addition–fragmentation chain transfer (RAFT)
polymerization technique has been used for preparation of a
number of well-dened polymers having only primary and/orPolym. Chem., 2014, 5, 1593–1604 | 1593
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View Article Onlinetertiary amine groups.20–31 Some of these polymers could be
used efficiently to complex nucleic acid therapeutics and dis-
played to a certain degree endosome escaping ability possibly
through the proton-sponge effect.27,29–31 A few polymers with
proton-sponge capacity were also derived from functional
polymer precursors such as oxazoline and pentauorophenyl
ester polymers synthesized via RAFT polymerization.22,32,33
In this study, we intended to synthesize a new, spermine/
spermidine-like polymer via RAFT polymerization as a potential
endosomal escaping agent. The ability of the RAFT technique to
yield polymers with controlled molecular weight, narrow
molecular weight distribution, controlled structure and end-
group functionality makes this technique an excellent synthetic
tool to prepare polymer therapeutics.34–40 Firstly, a new meth-
acrylate monomer, namely 2-((tert-butoxycarbonyl)(2-((tert-
butoxycarbonyl)amino)ethyl)amino)ethylmethacrylate (BocAEA-
EMA), was prepared and then polymerized via RAFT polymeri-
zation. A series of RAFT polymerization kinetics experiments
were performed in order to investigate the RAFT-controlled
character of polymerizations. Following the deprotection of the
amine groups to yield P(AEAEMA), the in vitro cytotoxicity on
NIH 3T3 cells and the proton sponge capacity of polymers in
comparison with PEI were investigated. Furthermore, the
P(BocAEAEMA) macro-RAFT agent was chain extended with a
mannose–acrylate monomer (ManAc), and then deprotected to
yield P(AEAEMA)-b-P(ManAc). The nucleic acid complexation
ability of the copolymer and the particle size of the nanoplexes
formed have been investigated. The results of these experiments
are presented below.
Experimental
Materials
N-Hydroxyethylethylenediamine (99% purity) and di-tert-butyl
dicarbonate were purchased from Aldrich to use in the
synthesis of tert-butyl(2-((tert-butoxycarbonyl)amino)ethyl)(2-
hydroxyethyl)carbamate according to the procedure reported by
Moura et al.41 Methacryloyl chloride was purchased
from Aldrich. tert-Butyl(2-((tert-butoxycarbonyl)amino)ethyl)(2-
hydroxyethyl)carbamate was methacrylated according to the
procedure reported previously.42,43 A chain transfer agent, 4-
cyano-4-(phenylcarbonothioylthio) pentanoic acid (CPADB),
was purchased from Aldrich. 2,20-Azobis(2-methylpropionitrile)
(AIBN) was used aer recrystallization twice in methanol. Silica
gel (pore size 60 A˚, 70–230 mesh) was purchased from Fluka.
Acetic acid, sodium acetate, citric acid and mono- and dibasic
phosphate salts were used to prepare buffer solutions and
purchased from Merck. Polyethyleneimine (branched, Mn:
25 kDa and 60 kDa; and linear, Mn: 8 kDa) was purchased from
Sigma-Aldrich and Fluka.
Toluene, ethylacetate, hexane, dichloromethane (DCM), tri-
uoroacetic acid, deuterium oxide (D2O), deuterium chloroform
(CDCl3), triethylamine (TEA), hexylamine, diethyl ether, meth-
anol and N0,N0-dimethylacetamide (DMAc, HPCL grade
$99.9%) were purchased from Sigma. The dialysis membrane
(MWCO ¼ 500–1000 Da) was purchased from Spectrum®
Laboratories.1594 | Polym. Chem., 2014, 5, 1593–1604DMEM (Dulbecco's Modied Eagle's Medium), L-glutamine,
trypsin and FBS (Foetal Bovine Serum) were obtained from
Gibco. PBS (phosphate buffer saline solution, pH 7.1) was
prepared using relevant mono- and dibasic salts and NaCl. The
thiazolyl Blue Tetrazolium Blue (MTT) reagent was bought from
Sigma-Aldrich. The epithelial mouse broblast (NIH 3T3) cell
line was kindly provided by Bioengineering Research and
Application Centre (˙Izmir Institute of Technology, Turkey).
The mannose acrylate (ManAc) monomer was synthesized
according to a procedure reported in the literature (Fig. S1–13,
ESI†).44 Ethidium bromide (Sigma), agarose (Sigma), 1 TAE
buffer and 100 bp-marker (Fermentas, gene ruler) were kindly
provided by Bioengineering Research and Application Centre
(˙Izmir Institute of Technology, Turkey). The 700-bp DNA frag-
ment was kindly provided by Dr G. Mese-Ozcivici (Department
of Molecular Biology and Genetics, I˙zmir Institute of Tech-
nology, Turkey).Instrumental methods
Nuclear magnetic resonance spectroscopy. 1H NMR spec-
troscopy (Varian, VNMRJ 400 spectrometer) was used to deter-
mine the chemical structure of compounds synthesized and the
conversion of the monomers during polymerizations. Samples
were dissolved at 10 mg ml1 concentration in D2O or CDCl3
depending on the solubility of the samples.
Gel permeation chromatography. Gel permeation chroma-
tography was used to determine the molecular weight and
molecular weight distribution of polymers. A Shimadzu
modular system comprising an SIL-10AD auto-injector, PSS
Gram 30 A˚ and 100 A˚ (10 mM, 8 300 mm) columns, an RID-10A
refractive-index detector and an SPD-20A prominence UV-vis
detector calibrated with narrow polydisperse poly(methyl
methacrylate) standards (410–67 000 g mol1) was used for
analysing P(BocAEAEMA). The mobile phase was N0,N0-dime-
thylacetamide containing 0.05% w/v LiBr. GPC measurements
of P(AEAEMA)-b-P(ManAc) (performed at University of Warwick)
was conducted on a Varian 390-LC system in DMF (1 g L1 LiBr)
at 50 C, equipped with refractive index, viscometry and UV
absorption detectors, 2  PLgel 5 mm mixed-D columns (300 
7.5 mm), 1  PLgel 5 mm guard column (50  7.5 mm) and
autosampler. Narrow linear poly(methyl methacrylate) stan-
dards in the range of 200 to 1.0  106 g mol1 were used for
calibration.
UV-visible spectrophotometry. UV-visible spectrophotometry
was used to investigate the aminolysis of the RAFT end-group of
BocAEAEMA polymers. The UV-visible absorbance of the RAFT
end-group was measured using a Thermo Scientic Evolution
201 UV-visible spectrophotometer in the range between 200 nm
and 600 nm using quartz cuvettes. Briey, the polymer was
dissolved in methanol at a concentration of 0.004 M. Hexyl-
amine (0.04 M) and triethylamine (0.04 M) were then added to
polymer solution. The aliquot of 10 ml was diluted to 600 ml with
methanol before the measurement was taken. The absorbance
of the diluted solution was scanned at 0, 5 h and 7 h of reaction.
Microplate reader. In cytotoxicity analysis, a Thermo Elec-
tron Corporation Varioskan microplate reader was used toThis journal is © The Royal Society of Chemistry 2014
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View Article Onlinemeasure the absorbance of cell solutions in a 96-well plate at
540 nm.
Agarose gel electrophoresis. The electrostatic complexation
of DNA with polymers was investigated by agarose gel electro-
phoresis using a Thermo Scientic Owl™ EasyCast™ B1 mini
gel system.
Dynamic light scattering. Particle size measurements of
polyplexes of DNA with polymers were performed using a Mal-
vern NanoZS Particle Analyzer System.
Synthetic methods
Synthesis of 2-((tert-butoxycarbonyl)(2-((tert-butox-
ycarbonyl)amino)ethyl)amino)ethyl methacrylate (BocAEAEMA)
(2). The amine containing monomer was synthesized according
to the procedure shown in Scheme 1. The primary and
secondary amine groups of N-(2-hydroxyethyl)ethylenediamine
were rst protected using di-tert-butyl dicarbonate according to
the procedure reported by Moura et al.41 Briey, N-(2-hydrox-
yethyl)ethylenediamine (0.024 mol, 2.43 ml) was dissolved in
dry DCM (40 ml) at10 C. Di-tert-butyl dicarbonate (0.048mol)
was dissolved in dry DCM (40 ml). Di-tert-butyl dicarbonate
solution was added dropwise into N-(2-hydroxyethyl)ethyl-
enediamine solution at 10 C. The nal solution was purged
with nitrogen for about 3 h and stirred for 24 h at room
temperature under nitrogen atmosphere. Aer reaction, the
precipitate formed during the reaction was separated by ltra-
tion. In order to remove the unreacted N-hydrox-
yethylethylenediamine, water–DCM extraction was performed
three times. The organic phases were collected and the solvent
was removed using a rotary evaporator. The product, tert-butyl-
2-(((tert-butoxycarbonyl)amino)ethyl)(2-hydroxyethyl)carbamate
(BocAEAE) (1) was collected as a yellow oil (reaction yield: 64%;
total yield: 64%).
1H NMR (CDCl3, d in ppm): 5.14–4.97 (s, 1H, –CH2–NH–
(COO(CH3)3)), 3.71 (t, 2H, –CH2–CH2–OH), 3.33–3.20 (t, 6H, OH–
CH2–CH2–N(COO(CH3)3–CH2–CH2–NH(COO(CH3)3), 1.49–1.39
(s, 18H–N(COO–(CH3)3))–CH2–CH2–NH–(COO(CH3)3).
BocAEAE (1) (0.0154 mol) was dissolved in dry DCM (40 ml)
at 0 C. Triethylamine (0.043mol) was dropped into the solution
under N2. The solution was stirred for 30 min. Finally, meth-
acryloyl chloride (0.029 mol) was added dropwise into the
solution. The nal solution was stirred for 4 h at 0 C under N2
and for a further 15 h at room temperature. Aer reaction, the
solution was ltered to remove the salt formed during reaction.
The reaction solution was extracted rst with brine solution
(three times) and then with water (three times). The organicScheme 1 Synthesis of the amine containing monomer, 2-((tert-
butoxycarbonyl)(2-((tert-butoxycarbonyl)amino)ethyl)amino)ethyl meth-
acrylate (BocAEAEMA).
This journal is © The Royal Society of Chemistry 2014phases were collected and the solvent was evaporated using a
rotary evaporator. The product was further dried in a vacuum
oven. The product was then puried by silica gel column
chromatography using hexane (Hxn) and ethylacetate (EA) at
varying volume ratios (Hxn : EA ¼ 1 : 0; 10 : 1; 8 : 1; 6 : 1; 4 : 1;
2 : 1; 0 : 1). The nal product, 2-((tert-butoxycarbonyl)(2-((tert-
butoxycarbonyl)amino)ethyl)amino)ethylmethacrylate (BocAEA-
EMA) (2), was obtained as a yellow oil (Rf ¼ 0.19 in Hxn : EA ¼
4 : 1; total yield: 84%).
1H NMR (CDCl3, d in ppm): 6.11–5.58 (s, 2H, CH2]C(CH3)
COO–), 1.94 (s, 3H, CH2]C–CH3), 4.25–4.23 (t, 2H, –COO–CH2–),
3.50–3.27 (t, 6H, –CH2–N(COO(CH3)3–CH2–CH2–
NH(COO(CH3)3))), 1.45–1.42 (s, 18H, –N(COO–(CH3)3)–CH2–
CH2–NH–(COO(CH3)3), 4.99–4.79 (s, 1H, –CH2–NH–(COO(CH3)3).
RAFT polymerization of 2-((tert-butoxycarbonyl)(2-((tert-butox-
ycarbonyl)amino)ethyl)amino)ethyl methacrylate (BocAEAEMA).
The polymerization scheme and conditions are given in Scheme 2
and Table S1 (ESI†), respectively. Briey, in a representative poly-
merization procedure (Exp. 3, Table S1, ESI†) BocAEAEMA (2)
(5.37  104 mol), CPADB (1.07  105 mol) and AIBN (2.69 
106 mol) were dissolved in toluene (540 ml). The total volume of
the reaction mixture was 750 ml. The solution was purged with N2
for 15 min. The reaction solution was then immersed in an oil
bath at 65 C. At the end of the reaction time, polymerization was
stopped by cooling the solution in an ice bath and exposing the
solution to air. The solvent was removed under vacuum.Monomer
conversions were determined via 1H-NMR spectroscopy using
CDCl3 as a solvent. Polymers (P(BocAEAEMA)) (3) were puried by
precipitating the polymerizationmixture in hexane (approximately
9 times). The number average molecular weight (Mn) and molec-
ular weight distribution (PDI) were determined by GPC using
DMAc as a mobile phase. Molecular weights were also calculatedScheme 2 Synthesis of poly(2-((tert-butoxycarbonyl)(2-((tert-
butoxycarbonyl)amino)ethyl)amino)ethylmethacrylate) (P(BocAEA-
EMA)) (3) and copolymerization of the P(BocAEAEMA) macro-RAFT
agent with ManAc to yield P(BocAEAEMA)-b-P(ManAc) block
copolymers.
Polym. Chem., 2014, 5, 1593–1604 | 1595
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View Article Onlinefrom the 1H-NMR spectrum of puried polymers using eqn (1) in
which the molecular weight of the monomer and RAFT agent is
372.5 g mol1 and 279.4 g mol1, respectively.
1H NMR (CDCl3, d in ppm): 1.76 (s, 2H, –CH2–C(CH3)COO–),
0.89–0.73 (s, 3H, –CH2–C(CH3)COO–), 4.01 (t, 2H, –COO–CH2–),
3.50–3.27 (t, 6H, –CH2–N(COO(CH3)3–CH2–CH2–NH(COO(CH3)3)),
1.45–1.42 (s, 18H, –N(COO–(CH3)3)–CH2–CH2–NH–(COO(CH3)3),
4.98–4.77 (s, 1H, –CH2–NH–(COO(CH3)3).
MnNMR ¼
I@4:01 ppm
2
I@7:73 ppmþ I@7:52 ppmþ I@7:35 ppm
5
 Mwmonomer þMwRAFT (1)
Deprotection of P(BocAEAEMA). Three polymers having
different molecular weights Mn ¼ 11 500 Da, PDI ¼ 1.35 (GPC),
Mn ¼ 12 000 Da (NMR), DP ¼ 32 (NMR);Mn ¼ 13 500 Da, PDI ¼
1.41 (GPC),Mn¼ 16 500 Da (NMR), DP¼ 44 (NMR);Mn¼ 23 500
Da, PDI ¼ 1.40 (GPC), Mn ¼ 20 400 Da (NMR), DP ¼ 55 (NMR)
were deprotected in order to investigate their proton-sponge
capacity and in vitro cytotoxicity.
For deprotection of amino groups (removal of Boc groups)
(Scheme 3), polymer (3) (4.35 mmol, 52.2 mg for Mn ¼ 12 000
Da; 71,8 mg for Mn ¼ 16 500 Da; 88.7 mg for Mn ¼ 20 400 Da)
was dissolved in DCM (1 ml) and triuoroacetic acid (0.5 ml)
was added dropwise into the solution at 0 C. The nal
solution was stirred for 30 min at room temperature. The
solvent was removed by purging N2 at room temperature. The
reaction mixture was then washed with diethyl ether and
chloroform more than three times and nally the sample was
dried in a vacuum oven. The deprotected polymer, poly-
(2-(aminoethyl)-amino)ethylmethacrylate, P(AEAEMA) (4),
was characterized by 1H-NMR spectroscopy aer dissolving in
D2O.
1H NMR (D2O, d in ppm): 4.15 (t, 2H, –COO–CH2–), 3.41–3.3
(t, 6H, –CH2–NH–CH2–CH2–NH2), 1.76 (s, 2H, –CH2–C(CH3)
COO–), 0.89–0.73 (s, 3H, –CH2–C(CH3)COO–).
The deprotection yield was calculated using eqn (2).
Deprotection yield% ¼
I@4:15 ppm
2
I@1:48 ppm
18
þ I@4:15 ppm
2
 100
(2)Scheme 3 Deprotection of poly[2-((tert-butoxycarbonyl)(2-((tert-
butoxycarbonyl)amino)ethyl)amino)ethylmethacrylate) (P(BocAEAEMA)
(3) to yield poly(2-(aminoethyl)amino)ethylmethacrylate], P(AEAEMA) (4).
1596 | Polym. Chem., 2014, 5, 1593–1604The Mn (NMR) of the resultant polymers aer deprotection
was calculated theoretically, considering that all Boc groups
were removed from the polymers. Thus the resultant depro-
tected polymers P(AEAEMA) having a Mn,theo aer deprotection of
5500 Da (DP ¼ 32), 8000 Da (DP ¼ 44) and 10 000 Da (DP ¼ 55)
were used for further experiments.
Chain extension of the P(BocAEAEMA) macro-RAFT agent
with ManAc. P(BocAEAEMA) (30 mg, 0.0058 mmol) was used as
a macro-RAFT agent and dissolved in DMF (2 ml). The ManAc
glycomonomer (111.5 mg, 0.3 mmol) and AIBN (0.095 mg,
0.0057 mmol) were added into the solution. The reaction solu-
tion was transferred into a Schlenk tube. The solution was
degassed by gentle bubbling of nitrogen for 20 minutes and
then placed into an oil bath at 70 C for 12 hours. The reaction
was stopped via exposure to air and then the reaction mixture
was dialysed against methanol–water mixture for two days.
Finally, methanol was removed using a rotary evaporator and
the residue mixture was freeze-dried to obtain the block
copolymer (Scheme 2).
For deprotection of amino groups, P(BocAEAEMA)13-b-
P(ManAc)7 (Mn,GPC) ¼ 6850 Da; PDI ¼ 1.18) (10 mg) was dis-
solved in triuoroacetic acid (TFA) (0.5 ml) at 0 C. The nal
solution was stirred for 10 min at room temperature. TFA was
removed by purging N2 at room temperature. The reaction
mixture was then washed with diethyl ether and chloroform
more than three times and nally the sample was dried in a
vacuum oven. The deprotection process was veried by 1H-NMR
spectroscopy using D2O as a solvent (data not shown). TheMn of
the resultant polymer aer deprotection was calculated theo-
retically, considering that all Boc groups were removed from the
polymer. The resultant deprotected polymer (P(AEAEMA)13-b-
P(ManAc)7) had a Mn,theo aer deprotection of 4240 Da.
Determination of the proton sponge capacity of P(AEAEMA).
The proton sponge capacity of deprotected polymers was
determined in comparison with a well-known polycation used
in intracellular drug delivery, i.e. polyethyleneimine (branched,
Mn: 25 kDa and 60 kDa; and linear, Mn: 8 kDa). A protocol
reported previously31 was followed for determination of the
proton sponge capacity of polymers. In these experiments,
either the molar concentration of polymers or the repeating
units in polymers were kept constant to be able to compare the
proton sponge capacity of different types of polymers tested
(i.e. P(AEAEMA) and PEI having varying molecular weights).
Firstly, aqueous solutions of polymers ([polymer] ¼ 2.2 
105 M or [repeating unit] ¼ 2.9  104 M, in 10 ml) were
prepared and the pH of the solutions was adjusted to pH 12 by
adding NaOH (40%, w/v). The nal solution was then titrated by
addition of HCl solution (0.1 M) until the pH of the solution
decreased to 2. The pH of solutions was monitored using a
Hanna pH lab meter.
Determination of the in vitro cytotoxicity of P(AEAEMA).
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) cell viability assay was used to observe the effects of
P(AEAEMA) (Mn,theo aer deprotection ¼ 5500 Da, PDI: 1.35, (DP ¼
32), Mn,theo aer deprotection ¼ 8000 Da, PDI: 1.41 (DP ¼ 44) and
Mn,theo aer deprotection ¼ 10 000 Da (DP ¼ 55), PDI: 1.40) on the
viability of the mouse broblast NIH 3T3 cell line. The MTTThis journal is © The Royal Society of Chemistry 2014
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View Article Onlineassay measures the ability of living cells to reduce a tetrazolium
dye to insoluble formazan giving a purple colour. The cytotoxic
effect of PEI (branched, 25 000 and 60 000 Da; and linear, 8000
Da) was also determined in parallel to P(AEAEMA) for
comparison.
Prior to cytotoxicity assays, the thiocarbonylthio RAFT-end
group of P(AEAEMA) was removed from the polymers in order
to avoid possible cytotoxicity of these active groups.45 To
remove the RAFT-end group, protocols well-known in the
literature have been performed.46,47 Briey, P(AEAEMA) (1 eq.)
dissolved in methanol was reacted with the 2-((2-aminoethyl)
amino)ethylmethacrylate monomer (AEAEMA) (3 eq.) in the
presence of hexylamine (HEA) (10 eq.) and triethylamine (TEA)
(10 eq.) for 3 hours under a N2 atmosphere at room tempera-
ture. The aminolysis kinetics was monitored via UV-vis spec-
troscopy by scanning the absorbance in the range between 200
and 600 nm. Aer reaction, the solvent was removed under
vacuum. The polymer was precipitated in diethyl ether and
then dried under vacuum. The product was characterized by
1H-NMR spectroscopy in D2O. Polymers were further puried
by dialysis against water using a membrane with a MW cut off
500–1000 Da for three days. The resultant polymers were then
dried using a freeze-dryer and then characterized using 1H-
NMR spectroscopy in D2O to ensure the complete removal of
impurities. Separately, P(BocAEAEMA) (Mn ¼ 11 kDa) was
aminolyzed using the same procedure and puried by precip-
itation in hexane. The nal product was characterized using
1H-NMR spectroscopy in DMSO-d6 to check whether there was
any transesterication side reaction occurred under the ami-
nolysis conditions applied.
In cytotoxicity analysis, NIH 3T3 cells were seeded a day
before to polymer sample exposure at 10 000 cells per well
(96-well plate) in culture medium containing 10% FBS–DMEM.
Polymer sample stocks were prepared in PBS solution and 5 ml
of polymer solution was added at predetermined concentra-
tions to cells. The cells were incubated at 37 C/5% CO2 for 24 or
72 h. The culture medium was removed from the wells aer the
incubation period. The solution of MTT dye was prepared with
culture medium (10% v/v). MTT solution (100 ml) was added to
wells according to the manufacturer's protocol. The plates were
incubated at 37 C for another 4 h. Aer 4 h, the 96-well plate
was centrifuged at 1800 rpm for 10 min, MTT solution was then
removed. DMSO (100 ml) was added to wells to dissolve the
crystals. In order to detect metabolic activity, the absorbance of
the solutions was recorded at 540 nm using a microplate reader.
The cell viability (%) was calculated relative to the positive
control (cells not treated with polymers) according to eqn (3) in
which Acell+sample is the absorbance of the cells treated with
polymer and Apositive control is the absorbance of the nontreated
cells.
Cell viability% ¼ Acellþsample
Apositive control
 100 (3)
Determination of polyplex formation by agarose gel elec-
trophoresis. In order to determine DNA binding ability of
P(AEAEMA) (Mn,theo aer deprotection ¼ 5500 Da (DP ¼ 32), 8000This journal is © The Royal Society of Chemistry 2014Da (DP ¼ 44) and 10 000 Da (DP ¼ 55)) and P(AEAEMA)13-b-
P(ManAc)7 (Mn,theo aer deprotection ¼ 4240 Da), polymers were
complexed with 700 bp DNA at three different nitrogen/
phosphate (N/P) ratios (20/1, 10/1 and 2/1). Polymers were
dissolved at an appropriate concentration in phosphate–
citrate buffer at pH 5.5 (8 ml) and mixed with DNA solution in
Tris–EDTA buffer (33 ng ml1, 1.8 ml). Polymer–DNA solutions
were incubated at room temperature for 15 min and then
loaded into 1% agarose gel stained with ethidium bromide.
The gel was run at 100 V for 55 min using TAE as a running
buffer. For comparison, the polyplex formation was also
investigated using PEI (25 000 Da) following the same proce-
dures given above.
Determination of the polyplex size by dynamic light scat-
tering (DLS). The polyplexes were formed at a N/P ratio of 20
according to the procedure described above. Polymer solution
at an appropriate concentration in phosphate–citrate buffer at
pH 5.5 (24 ml) was added into DNA solution in Tris–EDTA buffer
(33 ng ml1, 5.46 ml). The nal polyplex solution was diluted to
986.5 ml with ultrapure water. The polyplexes were incubated for
15 min before particle size analysis. Each sample was analyzed
three times for 72 and/or 30 runs.
Results and discussion
Synthesis of 2-((tert-butoxycarbonyl)(2-((tert-butoxycarbonyl)-
amino)ethyl)amino)ethylmethacrylate
A new, spermine-like amine containing monomer, 2-((tert-
butoxycarbonyl)(2-((tert-butoxycarbonyl)amino)ethyl)amino)-
ethyl methacrylate was rst synthesized. The synthesis proce-
dure was composed of two steps. The rst step was to protect
the primary and secondary amine groups of N-hydroxy-
ethylethylenediamine in order to prevent any possible
unwanted side reactions. The amine groups were protected
using di-tert-butyl dicarbonate (Boc) based on a method repor-
ted by Moura et al.41 The Boc group has been widely used in
peptide synthesis for protection of a- and side chain-amine
groups of amino acids. 1H-NMR spectra of N-hydroxy-
ethylethylenediamine before and aer protection are shown in
Fig. S14 (ESI).† The characteristic chemical shi of amine
groups in N-hydroxyethylethylenediamine at 2.20 ppm dis-
appeared completely aer the protection process. The charac-
teristic proton signals of the Boc group appeared clearly
between 1.39 and 1.49 ppm.
In the second step, the amine-protected product, tert-
butyl (2-((tert-butoxycarbonyl)amino)ethyl)(2-hydroxyethyl)-
carbamate, was reacted with methacryloyl chloride to prepare
the nal methacrylate monomer following a method reported
elsewhere.42,43 The yield of the reaction was determined to be
84% from the 1H-NMR spectrum of the reaction mixture
(Fig. S15, ESI†). The nal pure product, 2-((tert-butoxy-
carbonyl)(2-((tert-butoxycarbonyl)amino)ethyl)amino)ethyl
methacrylate (BocAEAEMA), obtained aer column chroma-
tography was characterized by 1H-NMR spectroscopy (Fig. 1).
The characteristic signals of vinyl protons, –CH2 and –CH3,
were observed at 6.11 ppm (1H), 5.58 ppm (1H) and
1.94 ppm (3H), respectively. Upon methacrylation, the signalPolym. Chem., 2014, 5, 1593–1604 | 1597
Fig. 1 1H-NMR spectrum of pure 2-((tert-butoxycarbonyl)(2-((tert-
butoxycarbonyl)amino)ethyl)amino)ethyl methacrylate (BocAEAEMA)
obtained after column chromatography.
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View Article Onlineof protons of –CH2– adjacent to the –OH group in tert-bu-
tyl(2-((tert-butoxycarbonyl)amino)ethyl)(2-hydroxyethyl)carba-
mate, which was located at 3.71 ppm (Fig. S14, ESI†) clearly
shied to 4.25–4.23 ppm in the nal product (Fig. 1) indicating
the formation of an ester bond (–CH2–CH2–O–C(]O)–).Fig. 2 Kinetic plots of RAFT polymerization of BocAEAEMA performed
at a monomer concentration of 0.72 M and varying ratios of [M]/[R]/[I].RAFT polymerization of BocAEAEMA
2-((tert-Butoxycarbonyl)(2-((tert-butoxycarbonyl)amino)ethyl)-
amino)ethyl methacrylate (BocAEAEMA) was polymerized
via RAFT polymerization using 4-cyano-4-(phenyl-
carbonothioylthio) pentanoic acid (CPADB) as a RAFT agent.
CPADB has been widely used as a RAFT agent in controlling the
polymerization of methacrylates.48 RAFT polymerization
kinetics were investigated at varying [monomer]/[RAFT agent]
ratios ([M]/[R]: 25/1, 50/1 and 100/1) at a xed monomer
concentration of 0.72 M or at a xed initiator concentration of
3.6  103 M. In all polymerizations the ratio of the RAFT agent
concentration to the initiator concentration ([R]/[I]) was kept
constant at 1/0.25. Monomer conversion was calculated from
1H-NMR spectra of polymerization mixtures (Fig. S16, ESI†).
The number average molecular weights (Mn) and polydispersity
indices (PDI) of the synthesized polymers were determined by
gel permeation chromatography. TheMns were also determined
by NMR spectroscopy.
Table S1 (ESI†) shows the conversion, Mn and PDI values of
the polymers synthesized at a constant monomer concentration
of 0.72 M with varying [M]/[R]/[I] ratios. GPC chromatograms of
polymerization mixtures showed the increase in molecular
weight with time and the presence of monomodal distributions
(Fig. S17, ESI†). The increase in monomer conversion and
[M]/[R] ratio led to an increase inMn values. The PDI values were
below 1.36 for all polymerizations. In all polymerizations, ln
[M]0/[M] increased linearly with time (Fig. 2), indicating pseudo-
rst order behaviour of polymerization. The linear increase in
Mn with monomer conversion was also observed (Fig. 2). These
are all attributed to the known traits of the RAFT-controlled
polymerization mechanism.34,351598 | Polym. Chem., 2014, 5, 1593–1604Table S1 (ESI†) and Fig. 3 present the effects of the [M]/[R]
ratio on the RAFT polymerization of BocAEAEMA performed
at a constant initiator concentration of 3.6  103 M and a
[R]/[I] ratio of 4. The [M]/[R] ratio, thus the monomer
concentration, was varied to be 25/1 (0.36 M), 50/1 (0.72 M) or
100/1 (1.44 M). Similar results indicating the RAFT-controlled
polymerization mechanism were obtained. The increase in
the monomer concentration led to an increase in free radical
polymerization rate, as expected.49 The kinetic plots revealed
the linear proportionality between ln[M]0/[M] and polymeri-
zation time, and Mn and conversion, proving the RAFT-
controlled mechanism. However, side reactions might have
occurred with the increase in [M]/[R] ratio, leading to signif-
icantly larger PDI values.This journal is © The Royal Society of Chemistry 2014
Fig. 3 Kinetic plots of RAFT polymerization of BocAEAEMA performed
at an initiator concentration of 3.6  103 M and varying ratios of [M]/
[R]/[I].
Fig. 4 1H-NMR spectrum of (A) 2-((tert-butoxycarbonyl)(2-((tert-
butoxycarbonyl)amino)ethyl)amino)ethyl methacrylate polymer,
P(BocAEAEMA), synthesized at a monomer concentration of 1.44 M,
[M]/[R]/[I] ratio of 100/1/0.25 (conversion ¼ 80%, Mn,GPC ¼ 19 000 Da,
PDI ¼ 1.31), and (B) after deprotection of the same polymer yielding
P(AEAEMA).
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View Article OnlineOverall results showed that the polymerization of a new
monomer, BocAEAEMA, in toluene using AIBN as an initiator
and CPADB as a RAFT agent displayed all characteristics of the
RAFT-controlled polymerization mechanism.
A representative 1H-NMR spectrum of puried
P(BocAEAEMA) synthesized at a monomer concentration of
1.44 M and a [M]/[R]/[I] ratio of 100/1/0.25 (conversion ¼ 80%,
Mn,GPC ¼ 19 000 Da, PDI ¼ 1.31) is given in Fig. 4(A). The
spectrum shows all signals expected for the polymer structure,
proving the successful synthesis of P(BocAEAEMA) by RAFT
polymerization.
Prior to proton sponge and cytotoxicity experiments, poly-
mers were deprotected to yield the nal amine-containing
spermine-like polymer structures. Fig. 4(B) shows the NMRThis journal is © The Royal Society of Chemistry 2014spectrum of a polymer synthesized at a monomer concentration
of 1.44M and a [M]/[R]/[I] ratio of 100/1/0.25 (conversion¼ 80%,
Mn,GPC ¼ 19 000 Da, PDI ¼ 1.31) obtained aer deprotection
and purication. It should be noted that the NMR spectrum of
the deprotected polymer was taken in D2O since the polymer
solubility aer removal of Boc groups changed dramatically,
indicating the enhanced polarity of the deprotected polymer.
The proton signals of Boc groups normally appear at 1.40 and
1.48 ppm completely disappeared in the spectrum of the
deprotected polymer, showing that the polymer amine groups
were fully deprotected, yielding P(AEAEMA). Molecular weights
of polymers aer deprotection were calculated theoretically by
subtracting the mass of Boc protection groups from the mass of
polymers determined by NMR.
Synthesis of P(BocAEAEMA)-b-P(ManAc)
In order to enhance the biocompatibility and serum stability of
polyplex particles to be formed with P(AEAEMA) and DNA and
more importantly give the particles specic cell-recognition
ability, block copolymers of P(BocAEAEMA) with a model sugar
block, poly(mannose-acrylate) P(ManAc), were prepared. ThePolym. Chem., 2014, 5, 1593–1604 | 1599
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View Article OnlineManAc glycomonomer was directly polymerized using
P(BocAEAEMA) as a macro-RAFT agent. This approach is rela-
tively straightforward as there is no need of post-polymerization
modications. The nal product was characterized by 1H NMR
and GPC, as illustrated in Fig. 5. GPC chromatograms showed
the chain extension of the P(BocAEAEMA) macro-RAFT agent
with ManAc monomer. The 1H NMR spectrum of the block
copolymer clearly showed the proton signals of the P(ManAc)
block. Prior to DNA complexation experiments,
P(BocAEAEMA)13-b-P(ManAc)7 was deprotected and character-
ized by 1H NMR spectroscopy (data not shown). The depro-
tection was veried by the complete disappearance of the
proton signals of Boc groups, normally appearing at 1.35 ppm
in the 1H-NMR spectrum of P(BocAEAEMA)13-b-P(ManAc)7
(in DMSO-d6) before deprotection. The molecular weight of
P(AEAEMA)13-b-P(ManAc)7 was calculated theoretically by sub-
tracting the mass of Boc protection groups from the molecular
weight of P(BocAEAEMA)13-b-P(ManAc)7 determined by GPC
and found to be 4240 Da.Proton sponge capacity of P(AEAEMA)
P(BocAEAEMA) synthesized at a monomer concentration of
1.44 M and a [M]/[R]/[I] ratio of 200/1/0.25 for 5–10 h (Mn,GPC ¼
11 500 Da, PDI ¼ 1.35, Mn,NMR ¼ 12 000 Da, DP ¼ 32; Mn,GPC ¼
13 500 Da, PDI ¼ 1.41, Mn,NMR ¼ 16 500 Da, DP ¼ 44; Mn,GPC ¼
23 500 Da, PDI ¼ 1.40,Mn,NMR ¼ 20 400 Da, DP ¼ 55) were used
in experiments performed to determine proton sponge capacity
and cytotoxicity. The molecular weight of these polymers aer
deprotection (Mn,aer deprotection) was 5500 Da (DP¼ 32), 8000 Da
(DP ¼ 44) and 10 000 Da (DP ¼ 55), respectively.Fig. 5 Representative GPC chromatogram and 1H NMR spectrum of
the prepared P(AEAEMA)-b-P(ManAc) block copolymer.
1600 | Polym. Chem., 2014, 5, 1593–1604The proton sponge capacity of P(AEAEMA) was investigated
in comparison to polyethyleneimine (PEI), a widely used poly-
mer in intracellular drug delivery because of its high buffering
capacity.13–17 P(AEAEMA) having a Mn, aer deprotection of 5.5 kDa,
8 kDa and 10 kDa and branched PEI of 25 kDa and 60 kDa, and
linear PEI of 8 kDa were rst titrated with 0.1 M HCl using
polymer solutions containing the same repeating unit concen-
tration (2.9  104 M) in order to eliminate the effect of
molecular weight differences between different polymers.
The titration curves obtained at the same repeating unit
concentration are presented in Fig. 6. When the differences in
the molecular weight of different polymers were eliminated, the
buffering capacity of P(AEAEMA) was found to be comparable
with that of PEI, a highly efficient proton sponge polymer. While
branched PEI (25 kDa) and linear PEI (8 kDa) required 53  1
and 65 mole HCl/mole repeating unit, respectively, P(AEAEMA)
havingMn of 10 kDa and 8 kDa required 56 1 and 58 4 mole
HCl per mole repeating unit, respectively, to drop the pH to
acidic pH values (Table 1). Although the repeating unit of
branched PEI contains a 3.5–4.0-fold higher number of primary
and/or secondary amine groups than that of P(AEAEMA), the
titration results suggest that the protonation of PEI repeating
units is possibly affected by the polyprotic nature of the mole-
cule. In polyprotic acids/bases, the deprotonation/protonation
of one of the closely associated acid/base groups inhibits
further proton dissociation/association from/to the same
molecule.50 The titration results clearly suggest that P(AEAEMA)
potentially offers a proton sponge effect comparable to PEI,
which strongly encourages the investigations on the use of
P(AEAEMA) as an endosomal-escaping agent.
Titrations were repeated using polymer solutions having the
same molar concentration (2.2  105 M) (Fig. 7). As expected,
the proton sponge capacity decreased with the decrease in the
molecular weight of polymers when the same molar concen-
tration solutions of polymers of varying molecular weights were
used. In the case of higher molecular weight branched PEIs
(25 kDa and 60 kDa), since the solutions contained a higherFig. 6 Proton sponge capacity of P(AEAEMA) (5.5, 8 and 10 kDa) and
PEI (branched; 25 kDa and 60 kDa, and linear 8 kDa). The repeating unit
concentration in all polymer solutions was kept the same (2.9 
104 M). The results are the average of three different experiments
(with the exception that the experiments with P(AEAEMA) having a Mn
of 5500 Da and PEI having a Mn of 8000 Da were performed once).
This journal is © The Royal Society of Chemistry 2014
Table 1 Proton sponge capacity of polymers
Polymers
HCl/polymer (mole
ratio)
HCl/repeat unit
(mole ratio)
PEI (60 kDa) 1230  21 47  2
PEI (25 kDa) 867  53 53  1
PEI (8 kDa) 877 65
P(AEAEMA) (10 kDa) 757  26 56  1
P(AEAEMA) (8 kDa) 601  34 58  4
P(AEAEMA) (5.5 kDa) 192  26 55
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View Article Onlinenumber of amine-containing repeating units, a higher amount
of HCl was needed to drop the pH of the PEI solutions, when
compared with the solutions of P(AEAEMA) having molecular
weights ranging from 5.5 kDa to 10 kDa. A linear PEI of 8 kDa
displayed higher proton sponge capacity than P(AEAEMA) of 8
kDa. The linear PEI solution contains a higher number of pro-
tonable amine groups than the solution of P(AEAEMA) at the
same concentration since the DP of linear PEI of 8 kDa is
approximately 186, while the DP of P(AEAEMA) of the same
molecular weight is 44.In vitro cytotoxicity of P(AEAEMA)
Before performing the cytotoxicity assays, the thiocarbonylthio
RAFT end-group of P(AEAEMA) was removed as this reactive
group might possess toxic effects on living cells. According to
the study of Pissuwan et al.,45 polymers synthesized via RAFT
polymerization using 4-cyano-4-(phenylcarbonothioylthio)
pentanoic acid as a RAFT agent have no toxicity on NIH 3T3 and
CHO–K1 cell lines over 72 h. However, the same study showed
that the RAFT end-group cytotoxicity depends on the types of
cell line and polymer. In order to avoid any possible toxic effects
of the RAFT end-group, the thiocarbonylthio end group of
polymers was cleaved to thiol in the presence of hexylamine,
triethylamine and AEAEMA monomer, following a procedureFig. 7 Proton sponge capacity of P(AEAEMA) (5.5, 8 and 10 kDa) and
PEI (branched; 25 kDa and 60 kDa, and linear 8 kDa). The polymer
concentration in all polymer solutions was kept the same (2.2 
105 M). The results are the average of three different experiments
(with the exception that the experiments with P(AEAEMA) having a Mn
of 5500 Da and PEI having aMn of 8000 Da were performed twice and
once, respectively).
This journal is © The Royal Society of Chemistry 2014reported previously in the literature.46,47 The 1H-NMR and UV-vis
spectra of P(AEAEMA) (Mn, aer deprotection ¼ 5.5 kDa) aer
aminolysis are shown in Fig. S18 and S19 (ESI).† Both the UV
and 1H-NMR analyses showed that the RAFT end-group of the
polymers was efficiently removed. Here it should be noted that
the 1H-NMR analysis of the aminolyzed polymer in DMSO-d6
(Fig. S18†) showed that there was no transesterication reaction
leading to the formation of poly(methyl methacrylate).
The effect of P(AEAEMA) Mn, aer deprotection ¼ 5.5 kDa (DP ¼
32), 8 kDa (DP¼ 44), and 10 kDa (DP¼ 55) on the viability of the
in vitro cultured mouse broblast NIH 3T3 cell line was inves-
tigated using MTT cell viability assay. P(AEAEMA)s at varying
concentrations (0.1 mM, 0.2 mM, 0.4 mM, 0.8 mM and 1.6 mM)
were incubated with cells for 24 h and 72 h. For comparison,
PEIs (branched, 25 kDa and 60 kDa; and linear, 8 kDa) were also
tested in the assays. The percentage of the cell viability was
determined with respect to untreated cells (cells with no poly-
mer treatment).
TheMTT assay results showed that P(AEAEMA)s did not have
any signicant cytotoxic effect on NIH 3T3 cells at all polymer
concentrations tested while PEIs (25 kDa and 60 kDa) were
highly toxic at a concentration of 0.4 mM and above even aerFig. 8 Viability of NIH 3T3 cells after incubation with P(AEAEMA)
(Mn, after deprotection ¼ 5.5 kDa, 8 kDa, and 10 kDa) and PEI (60 kDa and
25 kDa)s for (A) 24 h and (B) 72 h. Control is the cells with no treatment.
The polymer mass concentrations (mg L1) were as follows: 6, 12, 24,
48, 96 for PEI 60 kDa; 2.5, 5, 10, 20, 40 for PEI 25 kDa; 1, 2, 4, 8, 16 for
P(AEAEMA) 10 kDa; 0.8, 1.6, 3.2, 6.4, 12.8 for PEI and P(AEAEMA) 8 kDa;
0.55, 1.1, 2.2, 4.4, 8.8 for P(AEAEMA) 5.5 kDa.
Polym. Chem., 2014, 5, 1593–1604 | 1601
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View Article Online24 h incubation (Fig. 8). Similar to P(AEAEMA)s, linear PEI of
8 kDa had also no toxic effect. The less toxic effect of P(AEAEMA)
s and PEI 8 kDa may be attributed to the fact that the solutions
of the low molecular weight polymers (P(AEAEMA)s and PEI of
8 kDa) contain less number of amine groups when compared
with the solutions of high molecular weight polymers (PEI
25 kDa and 60 kDa) at the same molar concentrations. The cell
viabilities above 100% might be due to the potential effect of
amine-containing polymers on cell metabolism or an articial
side reaction of these polymers with assay reagents or products,
which is usually tolerated for longer incubation times
(e.g. 72 h).51Fig. 10 The number average particle size of polymer–DNA complexes
at an N/P ratio of 20, determined by dynamic light scattering.Polyplex formation with DNA
The ability of P(AEAEMA) and P(AEAEMA)-b-P(ManAc) to elec-
trostatically complex with DNA was rst tested by gel electro-
phoresis. P(AEAEMA)Mn, aer deprotection¼ 5.5 kDa (DP¼ 32) and
10 kDa (DP ¼ 55), P(AEAEMA)13-b-P(ManAc)7 (Mn, aer deprotection
¼ 4.24 kDa) and PEI (25 kDa) were incubated with a DNA
fragment of 700 bp at pH 5.5 (where most amine groups on the
polymers are estimated to be protonated) for 15 minutes. The
complexations were performed at three different nitrogen
(sourced from primary and secondary amine groups of poly-
mers)/phosphorus (sourced from phosphate groups of DNA)
(N/P) ratios (20, 10 and 2). As it can be seen in the gel electro-
pherogram (Fig. 9), DNA was fully complexed with PEI at all N/P
ratios tested, as evidenced by the absence of any free DNA band
of 700 bp (Lanes 2–4, Fig. 9). The same result was also observed
with P(AEAEMA)32 having a Mn,aer deprotection ¼ 5.5 kDa (Lanes
8–10). In the case of P(AEAEMA)55 with Mn,aer deprotection ¼
10 kDa, the DNA fragment could not be fully complexed with the
polymer at a N/P ratio of 2, while a complete complexation was
observed at higher N/P ratios (Lanes 5–7). Overall these results
proved that P(AEAEMA) was effective in forming polyplexes with
a DNA fragment. Also a lower Mn polymer appeared to interactFig. 9 Agarose gel electropherogram of polymer-DNA complexes.
Lane 1: DNA markers; Lanes 2–4: PEI (25 kDa)–DNA complexes
prepared at a N/P ratio of 20, 10 and 2, respectively; Lanes 5–7:
P(AEAEMA)55 (10 kDa)–DNA complexes prepared at a N/P ratio of 20,
10, and 2, respectively; Lanes 8–10: P(AEAEMA)32 (5 kDa)–DNA
complexes prepared at a N/P ratio of 20, 10, and 2, respectively; Lanes
11–13: P(AEAEMA)13-b-P(ManAc)7 (4.24 kDa)–DNA complexes
prepared at a N/P ratio of 20, 10, and 2, respectively.
1602 | Polym. Chem., 2014, 5, 1593–1604with a large DNA fragment easier than its higher Mn counter-
part, probably due to the less steric hindrance effect. In the case
of P(AEAEMA)13-b-P(ManAc)7, a full complexation could not be
observed at any of N/P ratios tested (Lanes 11–13). The presence
of the ManAc block clearly inhibited the interaction of the
P(AEAEMA) block with DNA. However, from the band intensi-
ties, it was clear that the complexation increased with
increasing N/P ratio.
Finally, the hydrodynamic diameter of polyplexes formed by
DNA and P(AEAEMA)32 (Mn,aer deprotection ¼ 5500 Da) or
P(AEAEMA)13-b-P(ManAc)7 (Mn,aer deprotection ¼ 4240 Da) at a
N/P ratio of 20 was investigated by DLS (Fig. 10). Naked DNA
displayed a hydrodynamic diameter of 88  24 nm. Upon
complexation of DNA with P(AEAEMA)32, formation of poly-
plexes having a hydrodynamic diameter of 125  51 nm was
observed. The high N/P ratio ensures that the polyplex particles
possess a positive surface charge which results in the repulsive
forces preventing the aggregation tendency between polyplex
particles. When complexation was performed with
P(AEAEMA)13-b-P(ManAc)7, the polyplex particles displayed a
much smaller hydrodynamic diameter (38  10 nm). In this
case, the presence of the hydrophilic glycopolymer block might
provide stability to polyplex particles in aqueous solution by
preventing the association of a higher number of polymeric
chains with DNA molecules, leading to the formation of parti-
cles with smaller hydrodynamic diameter. Additionally, as the
gel electrophoresis results also indicated, it is possible that the
shorter P(AEAEMA) block in the copolymer (with respect to the
homopolymer used) can interact with the DNA fragment more
efficiently, leading to a higher level of condensation of DNA
chains. These results are in agreement with previous work of
Ahmed and Narain,52 showing that the size of DNA polyplexes
depends on the architecture of the polymer, and the length of
the cationic chain. In this work, it was hypothesized that the
block copolymers composed of cationic and carbohydrate
blocks condense DNA efficiently in their core with a shell of the
carbohydrate segment and hence yielding smaller particles as
compared to statistical copolymers. Similarly, the same study
showed that a low molecular weight cationic homopolymer
formed smaller particles with plasmid DNA than higher
molecular weight counterparts.This journal is © The Royal Society of Chemistry 2014
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View Article OnlineConclusions
The aim of this study was to synthesize and characterize a new,
spermine-like, amine containing, well-dened polymer as a
potential endosomal escaping agent. For this purpose, a new
monomer, 2-((tert-butoxycarbonyl)(2-((tert-butoxycarbonyl)-
amino)ethyl)amino)ethylmethacrylate (BocAEAEMA), was
synthesized and polymerized via RAFT polymerization. Well-
dened BocAEAEMA polymers with controlled molecular
weights and narrow molecular weight distributions were
obtained. The polymers aer deprotection, P(AEAEMA) dis-
played proton sponge capacity comparable with a widely used
endosomal-disruptive polymer, PEI (25 kDa). More importantly,
P(AEAEMA) did not show a cytotoxic effect on mouse broblast
cells at concentrations where PEI was highly toxic. P(AEAEMA)
was able to fully condense a 700 bp DNA fragment at N/P ratios
of 10 and above. Moreover, RAFT-synthesized P(AEAEMA) could
be chain extended with a sugar monomer, ManAc, to yield
P(AEAEMA)-b-P(ManAc) block copolymers. Although the pres-
ence of the ManAc block partially inhibited the interaction of
P(AEAEMA) with DNA, the copolymer was able to form poly-
plexes with DNA at the N/P ratios tested.
Overall the results strongly encourage further investigations
on the use of P(AEAEMA) as an endosomal-escaping agent. The
endosomal escaping ability, intracellular distribution prole
and transfection ability of P(AEAEMA) are currently being
investigated in our laboratories.
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